Laurent M. Humeau
2023
In 2023, Laurent M. Humeau earned a total compensation of $1.1M as Chief Scientific Officer at Inovio Pharmaceuticals, a 27% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $168,264 |
---|---|
Option Awards | $218,593 |
Salary | $610,850 |
Stock Awards | $132,252 |
Other | $14,968 |
Total | $1,144,927 |
Humeau received $610.9K in salary, accounting for 53% of the total pay in 2023.
Humeau also received $168.3K in non-equity incentive plan, $218.6K in option awards, $132.3K in stock awards and $15K in other compensation.
Rankings
In 2023, Laurent M. Humeau's compensation ranked 1,032nd out of 2,785 executives tracked by ExecPay. In other words, Humeau earned more than 62.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,032 | 63rd |
Manufacturing | 616 | 60th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 76 | 67th |
Surgical, Medical, And Dental Instruments And Supplies | 49 | 70th |
Surgical and Medical Instruments and Apparatus | 44 | 65th |
Humeau's colleagues
We found two more compensation records of executives who worked with Laurent M. Humeau at Inovio Pharmaceuticals in 2023.
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021